SEC Filing: Form EFFECT
Notice of Effectiveness
VYNE TherapeuticsRooted in Innovation
VYNE Therapeutics
Notice of Effectiveness
Annual report [Section 13 and 15(d), not S-K Item 405]
Registration statement under Securities Act of 1933
Securities to be offered to employees in employee benefit plans